Voyager Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Voyager Therapeutics, Inc. (VYGR) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $15.53 per share as of 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2020-05-06
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $15.53.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $15.98.
- 2019-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $16.04.
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $15.76.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2020-03-31 | $15.53 10-Q · filed 2020-05-06 |
| 2019-12-31 | $15.98 10-K · filed 2020-03-03 |
| 2019-09-30 | $16.04 10-Q · filed 2019-11-06 |
| 2019-06-30 | $15.76 10-Q · filed 2019-08-09 |
| 2019-03-31 | $14.99 10-Q · filed 2019-05-07 |
| 2018-12-31 | $15.91 10-K · filed 2019-02-26 |
| 2018-09-30 | $16.02 10-Q · filed 2018-11-07 |
| 2018-06-30 | $15.41 10-Q · filed 2018-08-07 |
| 2018-03-31 | $14.92 10-Q · filed 2018-05-10 |
| 2017-09-30 | $11.23 10-Q · filed 2017-11-02 |
| 2017-06-30 | $10.85 10-Q · filed 2017-08-08 |
| 2017-03-31 | $10.91 10-Q · filed 2017-05-09 |
| 2016-09-30 | $10.01 10-Q · filed 2016-11-10 |
| 2016-06-30 | $9.80 10-Q · filed 2016-08-11 |
| 2016-03-31 | $9.41 10-Q · filed 2016-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |